CD8 T Cell-intrinsic GITR is Required for T Cell Clonal Expansion and Mouse Survival Following Severe Influenza Infection
Overview
Authors
Affiliations
The regulation of T cell expansion by TNFR family members plays an important role in determining the magnitude of the immune response to pathogens. As several members of the TNFR family, including glucocorticoid-induced TNFR-related protein (GITR), are found on both regulatory and effector T cells, there is much interest in understanding how their effects on these opposing arms of the immune system affect disease outcome. Whereas much work has focused on the role of GITR on regulatory T cells, little is known about its intrinsic role on effector T cells in an infectious disease context. In this study, we demonstrate that GITR signaling on CD8 T cells leads to TNFR-associated factor (TRAF) 2/5-dependent, TRAF1-independent NF-κB induction, resulting in increased Bcl-x(L). In vivo, GITR on CD8 T cells has a profound effect on CD8 T cell expansion, via effects on T cell survival. Moreover, GITR is required on CD8 T cells for enhancement of influenza-specific CD8 T cell expansion upon administration of agonistic anti-GITR Ab, DTA-1. Remarkably, CD8 T cell-intrinsic GITR is essential for mouse survival during severe, but dispensable during mild respiratory influenza infection. These studies highlight the importance of GITR as a CD8 T cell costimulator during acute viral infection, and argue that despite the similarity among several TNFR family members in inducing T lymphocyte survival, they clearly have nonredundant functions in protection from severe infection.
Franzese O Int J Mol Sci. 2024; 25(23).
PMID: 39684559 PMC: 11641238. DOI: 10.3390/ijms252312848.
Moussa P, Kurzrock R, Nishizaki D, Miyashita H, Lee S, Nikanjam M Am J Cancer Res. 2024; 14(4):1634-1648.
PMID: 38726288 PMC: 11076267. DOI: 10.62347/ECED5481.
GITR activation impairs CD8 T cell function in people with HIV on antiretroviral therapy.
Gubser C, Pascoe R, Chang J, Chiu C, Solomon A, Cao R iScience. 2023; 26(11):108165.
PMID: 38026168 PMC: 10660494. DOI: 10.1016/j.isci.2023.108165.
Prognostic Factors in Advanced Non-Small Cell Lung Cancer Patients Treated with Immunotherapy.
Rocco D, Della Gravara L, Ragone A, Sapio L, Naviglio S, Gridelli C Cancers (Basel). 2023; 15(19).
PMID: 37835378 PMC: 10571734. DOI: 10.3390/cancers15194684.
Targeting GITR in cancer immunotherapy - there is no perfect knowledge.
Davar D, Zappasodi R Oncotarget. 2023; 14:614-621.
PMID: 37335294 PMC: 10278658. DOI: 10.18632/oncotarget.28461.